The Notice of Allowance from the USPTO indicates that Applied DNA Sciences is likely to receive a patent for its RNA synthesis methods. This strengthens the company's intellectual property portfolio, which can enhance its competitive position and open up new revenue streams. Investors may view this development positively, leading to a potential short-term increase in the stock price.